Professor, Department of Pathology
Chief of Molecular Pathological Epidemiology (MPE) Program in the Department of Pathology, Brigham and Women's Hospital
Professor (Epidemiology) at Harvard T.H. Chan School of Public Health; Associate Member of Broad Institute of MIT and Harvard
Shuji Ogino, MD, PhD, MS, is the founding Chief of Molecular Pathological Epidemiology (MPE) Program, Brigham and Women’s Hospital; Professor of Pathology, Harvard Medical School; Professor (Epidemiology), Harvard T.H. Chan School of Public Health; Associate Member of Broad Institute of MIT and Harvard; Member of DFHCC Cancer Immunology Program. Dr. Ogino established the International Molecular Pathological Epidemiology (MPE) Meeting Series in 2013 and has been serving as its Chair/Co-Chair. He spearheads the integrative science of MPE, to study the interactive roles of environment (i.e., the exposome including diet, food and nutrition), microbiome, immunity, and tumor in carcinogenesis. He conducts multifaceted MPE studies using large-scale prospective cohort studies, having discovered the link between fiber-poor / inflammatory diet and higher incidence of colorectal cancer enriched with Fusobacterium nucleatum as well as evidence for suppressive effect of F. nucleatum on T-cell-mediated antitumor immunity. For his unique transdisciplinary scientific contribution, Dr. Ogino has received many awards and honors.